1. 要旨
2. 分類学と市場定義を含む業界紹介
3. 市場動向と成功要因（マクロ経済要因、市場ダイナミクス、最近の業界動向など
4. 歴史分析と将来予測を含む世界市場の需要分析2019年～2023年および予測2024年～2034年
5. 世界市場の分析 2019～2023年および2024～2034年予測
5.1. 医薬品タイプ
5.2. 催吐性リスク
5.3. 剤形
5.4. 流通経路
6. 医薬品タイプ別世界市場分析2019〜2023年および予測2024〜2034年
6.1. 5-HT3受容体拮抗薬
6.2. ニューロキニン-1受容体拮抗薬
6.3. 副腎皮質ステロイド
6.4. カンナビノイド受容体作動薬
6.5. その他
7. 催吐性リスク別の世界市場分析2019～2023年および予測2024～2034年
7.1. 催吐性の高い化学療法（HEC）
7.2. 中等度催吐性化学療法（MEC）
7.3. 低催吐性化学療法（LEC）
8. 形態別の世界市場分析2019～2023年および予測2024～2034年
8.1. 注射剤
8.2. 経口剤
8.3. 経皮吸収パッチ
9. 世界市場分析2019～2023年および予測2024～2034年：流通チャネル別
9.1. 病院
9.2. がん研究機関
9.3. 小売薬局
9.4. オンライン薬局
9.5. ドラッグストア
10. 世界市場分析2019～2023年および予測2024～2034年、地域別
10.1. 北米
10.2. 中南アメリカ
10.3. 西ヨーロッパ
10.4. 東欧
10.5. 東アジア
10.6. 南アジア・太平洋
10.7. MEA
11. 北米の主要セグメント・国別売上高分析 2019～2023年および予測 2024～2034年
12. 中南アメリカ売上高分析 2019～2023年および2024～2034年予測：主要セグメント・国別
13. 西欧売上高分析 2019～2023年および2024～2034年予測：主要セグメント・国別
14. 東欧の売上高分析 2019～2023年および2024～2034年予測：主要セグメント・国別
15. 東アジアの売上高分析 2019～2023年および2024～2034年予測：主要セグメント・国別
16. 南アジア・太平洋地域 売上高分析 2019～2023年および2024～2034年予測：主要セグメント・国別
17. MEA売上高分析 2019～2023年および2024～2034年予測：主要セグメント別、国別
18. 2024～2034年までの売上高予測：30ヵ国：薬剤タイプ、催吐性リスク、剤形、流通チャネル別
19. 市場構造分析、主要プレイヤー別企業シェア分析、競争ダッシュボードを含む競争展望
20. 企業プロフィール
20.1. Kyowa Kirin, Inc.
20.2. Pfizer Inc.
20.3. GlaxoSmithKline plc.
20.4. AbbVie Inc. （Allergan plc）
20.5. Merck & Co., Inc.
20.6. Bausch Health Companies Inc.
20.7. Novartis AG
20.8. Ono Pharmaceutical Co., Ltd.
20.9. Camurus AB
20.10. Heron Therapeutics, Inc.
20.11. その他の著名なプレーヤー
21. 使用される仮定と略語
22. 調査方法
Chemotherapy Induced Nausea and Vomiting Treatment Market - Scope of ReportA recent study by Fact.MR on the chemotherapy induced nausea and vomiting treatment market offers a 10-year forecast for 2024 to 2034. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering chemotherapy induced nausea and vomiting treatment.
The study also provides the dynamics responsible for influencing the future status of the chemotherapy induced nausea and vomiting treatment market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.
A list of prominent companies operating in the chemotherapy induced nausea and vomiting treatment market, along with their product portfolios, key strategies and SWOT analysis, enhances the reliability of this comprehensive research study.
Report Summary
The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of chemotherapy induced nausea and vomiting treatment across the globe.
A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of chemotherapy induced nausea and vomiting treatment during the forecast period. Price point comparison by region with global average price is also considered in the study.
Analysis on Market Size Evaluation
The market has been analyzed for each segment in terms of value (US$ Mn).
Estimates at global and regional levels for chemotherapy induced nausea and vomiting treatment are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report.
Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global chemotherapy induced nausea and vomiting treatment market.
Inspected Assessment on Regional Segments
Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the chemotherapy induced nausea and vomiting treatment market during the forecast period.
Country-specific valuation on demand for chemotherapy induced nausea and vomiting treatment has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.
Detailed breakup in terms of value & volume for emerging countries has also been included in the report.
In-depth Analysis on Competition
The report sheds light on leading manufacturers of chemotherapy induced nausea and vomiting treatment, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering chemotherapy induced nausea and vomiting treatment has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the chemotherapy induced nausea and vomiting treatment domain.
1. Executive Summary
2. Industry Introduction, including Taxonomy and Market Definition
3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
5.1. Drugs Type
5.2. Emetogenic Risk
5.3. Form
5.4. Distribution Channel
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Drugs Type
6.1. 5-HT3 Receptor Antagonists
6.2. Neurokinin-1 Receptor Antagonists
6.3. Corticosteroids
6.4. Cannabinoid Receptor Agonist
6.5. Others
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Emetogenic Risk
7.1. Highly Emetogenic Chemotherapy (HEC)
7.2. Moderately Emetogenic Chemotherapy (MEC)
7.3. Low Emetogenic Chemotherapy (LEC)
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Form
8.1. Injectable
8.2. Oral
8.3. Transdermal Patches
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel
9.1. Hospitals
9.2. Cancer Research Institutes
9.3. Retail Pharmacies
9.4. Online Pharmacies
9.5. Drug Stores
10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
10.1. North America
10.2. Latin America
10.3. Western Europe
10.4. Eastern Europe
10.5. East Asia
10.6. South Asia & Pacific
10.7. MEA
11. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
12. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
13. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
14. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
15. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
16. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
17. MEA Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
18. Sales Forecast 2024 to 2034 by Drugs Type, Emetogenic Risk, Form, and Distribution Channel for 30 Countries
19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
20. Company Profile
20.1. Kyowa Kirin, Inc.
20.2. Pfizer Inc.
20.3. GlaxoSmithKline plc.
20.4. AbbVie Inc. (Allergan plc)
20.5. Merck & Co., Inc.
20.6. Bausch Health Companies Inc.
20.7. Novartis AG
20.8. Ono Pharmaceutical Co., Ltd.
20.9. Camurus AB
20.10. Heron Therapeutics, Inc.
20.11. Other Prominent Players
21. Assumptions & Acronyms Used
22. Research Methodology
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
